Alzheimer’s disease, the most common form of dementia affecting more than three million Americans a year, has proven difficult to diagnose in earlier stages. But detecting and treating the condition ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

CryoET allows imaging without chemical fixation or dehydration disrupting the structure of biological ... and other structures were found. In tau proteins, there were clusters of filaments in ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Tau is a microtubule-associated protein that helps to stabilize the structure of neurons, specifically by supporting microtubules, cylindrical structures that contribute to cell motility ...

and the Universidad Pablo de Olavide (UPO), provides new insight into how these proteins disrupt brain circuits related to memory and emotions. Published in Molecular Psychiatry, the research ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid ... Published in Molecular Psychiatry (Nature group), the findings reveal ...

Tau protein and beta-amyloid, key factors in Alzheimer's disease, impact brain circuits differently, with tau affecting memory-related areas and beta-amyloid influencing emotional centers.